Q&A - BioTech Funding Portal

Content reflects the views of the posting party and is provided for informational purposes only. It does not constitute a solicitation, recommendation, endorsement, or investment advice by BioTech Funding Portal. All content is subject to the portal’s Community Content Guidelines.

Q&A Feed

Karin Hellsvik answered Jul 5

Thanks for following. Tell me more about Gene Traffic Control platform - what is that?

Hi Chris,
thanks for reaching out!
It's the name of our proprietary drug discovery engine. It is designed to study and modulate the chromatin regulatory system, which - in a simplified way - controls when, where, and in what order genes are expressed. By targeting these mechanisms, we hope to correc... more

Hi Chris,
thanks for reaching out!
It's the name of our proprietary drug discovery engine. It is designed to study and modulate the chromatin regulatory system, which - in a simplified way - controls when, where, and in what order genes are expressed. By targeting these mechanisms, we hope to correct abnormal gene expression that causes cancer.
less
- Biotechnology
1
Tyson Bertmaring answered Jun 28

Tyson, thanks for connecting. Ejoyed your article: https://www.biotech.fund/kb/article/cultivating-an-ecosystem-of-trust-through-principled-decision-making Dyno Frontiers Network sounds like a great model, how would you see that working for Glafabra?

Hi Chris - it would depend on your goals. Our goal is to maximize the number of AAV based gene therapies which can successfully benefit from the use of our AAV technology platform. Success in classical terms of safety and efficacy, but also in terms of lower cost, time and risk in drug development. ... more

Hi Chris - it would depend on your goals. Our goal is to maximize the number of AAV based gene therapies which can successfully benefit from the use of our AAV technology platform. Success in classical terms of safety and efficacy, but also in terms of lower cost, time and risk in drug development. So the decisions we make are deliberately made towards that aim. So for you, first defining what your goal is can help you determine IF a network strategy makes sense for you and if so, how to design it.

I presume your platform can be licensed to others, if so that is where a network strategy makes a lot of sense. Dyno doesn’t develop our own gene therapies and so a network is essential.

happy to chat more,

Tyson
less
- Advanced Therapeutics
1

Thanks for following. Tell me more about Gene Traffic Control platform - what is that?

Tyson, thanks for connecting. Ejoyed your article: https://www.biotech.fund/kb/article/cultivating-an-ecosystem-of-trust-through-principled-decision-making Dyno Frontiers Network sounds like a great model, how would you see that working for Glafabra?